Lipid-Based Drug Delivery for Pneumonia Treatment

Keyphrases

• Respiratory Infection 100%
• Therapeutic Efficacy 100%
• Pneumonia Treatment 100%
• Drug Solubility 100%
• Lipid-based Drug Delivery Systems 100%
• Virus 50%
• Lipids 50%
• Alternative Therapy 50%
• Pathophysiology 50%
• Physicochemical Properties 50%
• Therapeutic Agents 50%
• Pneumonia 50%
• Mortality Rate 50%
• Solid Lipid Nanoparticles 50%
• Fungi 50%
• Respiratory Tract 50%
• Public Health 50%
• Morbidity Rate 50%
• Lung Tissue 50%
• Antifungal Agents 50%
• High Mortality 50%
• Targeted Drugs 50%
• Antibiotic Agents 50%
• High Morbidity 50%
• Antivirus Agent 50%
• Liposomes 50%
• Drug Safety 50%
• Viral Pneumonia 50%
• Drug Deposition 50%
• Systemic Effects 50%
• Drug Carrier 50%
• Safety Self-efficacy 50%
• Onset of Action 50%
• Rapid Onset 50%
• Innovative Drug Delivery Systems 50%
• Pulmonary Route 50%
• Drug Accumulation 50%
• Fungal Pneumonia 50%
• Drug Permeation 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Antifungal Agent 100%
• Combination Therapy 100%
• Respiratory Tract Infection 100%
• Drug Solubility 100%
• Antibiotic Agent 50%
• Infection 50%
• Pathophysiology 50%
• Antivirus Agent 50%
• Mortality Rate 50%
• Drug Delivery System 50%
• Solid Lipid Nanoparticle 50%
• Morbidity 50%
• Respiratory Tract 50%
• Liposome 50%
• Virus Pneumonia 50%
• Drug Safety 50%
• Lung Mycosis 50%
• Antimicrobial Agent 50%
• Microsphere 50%